Search

Following an approval from the FDA in May 2020, the New England Journal of Medicine has published data from the phase I/II LIBRETTO-001 clinical trial of selpercatinib in advanced RET (REarranged during Transfection)-driven lung and thyroid cancers. MSK’s Alexander Drilon, MD, the recently appointed Chief of the Early Drug Development Service, serves as the lead investigator for multi-site clinical trial.

… Wednesday, August 26, 2020 Results Mark Significant Advances in Targeted Treatment for RET-Driven Cancers, Advancing the Field of Precision Medicine Following an approval from the U.S. Food and Drug Administration (FDA) in May 2020, the New England Journal of Medicine has published data from the phase

An effective treatment may have emerged for some people with uveal melanoma, a rare cancer that forms in the eye.

… Tuesday, May 11, 2021 Uveal melanoma (also called ocular melanoma) is a cancer that forms in the eye. Although rare, this malignancy is often fatal when it spreads to other parts of the body, which happens in about half of all cases. Memorial Sloan Kettering medical oncologist Alexander Shoushtari answers

Learn how MSK researchers are deploying mRNA vaccines against pancreatic cancer.

… Sunday, April 19, 2026 An experimental, individualized therapeutic cancer vaccine that uses messenger RNA (mRNA) to treat pancreatic cancer continues to show potential in a small patient group. Follow-up results from a phase 1 clinical trial show that nearly 90% of people whose immune systems responded

Gregory Mazo has been awarded the Chairman’s Prize for his first-author paper Spatial Control of Primary Ciliogenesis by Subdistal Appendages Alters Sensation-Associated Properties of Cilia, published in Developmental Cell in 2016.

… Tuesday, August 29, 2017 Gregory Mazo has been awarded the Chairman’s Prize for his first-author paper Spatial Control of Primary Ciliogenesis by Subdistal Appendages Alters Sensation-Associated Properties of Cilia , published in Developmental Cell in 2016. Greg, who successfully defended his dissertation

The recent marketing of "at home" genomic tests for disease risk may be premature, according to Dr. Kenneth Offit, MD, MPH, Chief of the Clinical Genetics Service at Memorial Sloan Kettering Cancer Center (MSKCC).

… Tuesday, March 18, 2008 The recent marketing of “at home” genomic tests for disease risk may be premature, according to Dr. Kenneth Offit, MD, MPH , Chief of the Clinical Genetics Service at Memorial Sloan Kettering Cancer Center (MSKCC). “Health professionals are now faced with the prospect of their

Meet Dr. Monique James, who is part of MSK’s Department of Psychiatry and Behavioral Sciences. Her journey with MSK started 18 years ago before she even started medical school. 

… Tuesday, January 21, 2025 In 2017, Monique James, MD joined the Department of Psychiatry and Behavioral Sciences at Memorial Sloan Kettering Cancer Center (MSK), but her journey with MSK started 18 years before she even started medical school.  “I worked as a session assistant — when they were called

Learn more about the work of MSK researchers being presented at the 2018 meeting of the American Society of Hematology.

… Monday, December 3, 2018 The American Society of Hematology (ASH) annual meeting is the world’s premier event devoted to the study of blood cancers and disorders. More than 25,000 people are attending the 2018 assembly, held December 1 through 4 in San Diego. Memorial Sloan Kettering researchers at the

A rare form of stomach cancer caused by an inherited gene mutation can be avoided by having the stomach removed — and many people can adjust to life afterward.

… Wednesday, November 16, 2016 Summary People with an inherited mutation in the CDH1 gene are at a very high risk of developing a rare type of stomach cancer . Having the stomach removed, which can be performed using minimally invasive methods, can eliminate this risk. Most people recover well from the

While there has been remarkable progress in the number of people surviving with stage 4 cancer, MSK remains dedicated to research that will spur much needed advances.

… Friday, January 16, 2026 There’s good news about surviving stage 4 cancer — meaning cancer that has spread to other parts of the body — according to the new  Cancer Facts and Figures report from the American Cancer Society. In a sign of remarkable progress over the past two decades, more than one-third

Using stem cells, scientists can create batches of cortical neurons to study schizophrenia and autism.

… Tuesday, January 24, 2017 Summary To study brain diseases, researchers need to produce abundant quantities of cortical neurons, which take a long time to develop naturally. A new study from MSK scientists shows how to dramatically decrease the time it takes to produce these important cells.  Highlights